Application | Comment | Organism |
---|---|---|
medicine | cigarette smokeinduced methylation of HtrA3 can contribute to the etiology of chemoresistant disease in smoking-related lung cancer | Homo sapiens |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
42000 | - |
x * 42000, SDS-PAGE | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
BEAS-2B cell | - |
Homo sapiens | - |
EKVX cell | - |
Homo sapiens | - |
H-650 cell | - |
Homo sapiens | - |
H-69AR cell | - |
Homo sapiens | - |
H-82 cell | - |
Homo sapiens | - |
HCC-2935 cell | - |
Homo sapiens | - |
HCC-4006 cell | - |
Homo sapiens | - |
HCC-827 cell | - |
Homo sapiens | - |
HOP-62 cell | - |
Homo sapiens | - |
lung cancer cell | primary cell | Homo sapiens | - |
NCI-H526 cell | - |
Homo sapiens | - |
Subunits | Comment | Organism |
---|---|---|
? | x * 42000, SDS-PAGE | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
HtrA3 | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | HtrA3 expression is reduced or completely lost in over 50% of lung cancer cell lines and primary lung tumors from heavy smokers. An increased frequency of methylation within the first exon of HtrA3 corresponds to a loss of HtrA3 expression, particularly in tumors from smokers. 4-(methylnitrosamino)-I-(3-pyridyl)-1-butanone results in HtrA3 downregulation with a corresponding increase in methylation. HtrA3 expression is reduced after 15 days of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone treatment (0.01 mM) | down |
Homo sapiens | treatment of HtrA3-deficient cell lines with 5-aza-2-deoxycytidine results in a dose-dependent increase in HtrA3 transcription. HtrA3 expression is induced by the histone deacetylase inhibitor LBH589 | up |